Max Jan
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Immunology top 2%
- Phagocytosis and Immune Regulation
- Immune Cell Function and Interaction
- Immune cells in cancer
- Immunotherapy and Immune Responses
Papers in
- Hematology 15
- Acute Myeloid Leukemia Research 8
- Multiple Myeloma Research and Treatments 4
- Hematopoietic Stem Cell Transplantation 4
- Chronic Myeloid Leukemia Treatments 4
- Oncology 15
- CAR-T cell therapy research 14
- Co-authors
- Irving L. Weissman (7 shared papers)Ravindra Majeti (7 shared papers)Mark Ping Chao (4 shared papers)Arash Ash Alizadeh (5 shared papers)Benjamin L. Ebert (9 shared papers)Stephen R. Quake (2 shared papers)Thomas M. Snyder (2 shared papers)Paresh Vyas (1 shared paper)
- Journals
- Blood (6 papers)Science Translational Medicine (3 papers)Blood Advances (3 papers)Nature Medicine (2 papers)Nature (2 papers)
- Partner nations
- United StatesUnited KingdomSpain
In The Last Decade
Max Jan
33 papers receiving 4.4k citations
Max Jan's Hit Papers
Peers
Comparison fields: 5 of 103
- Hematology 999
- Immunology 1.7k
- Oncology 1.7k
- Aging 65
- Genetics 339
Countries citing papers authored by Max Jan
This map shows the geographic impact of Max Jan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max Jan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max Jan more than expected).
Fields of papers citing papers by Max Jan
This network shows the impact of papers produced by Max Jan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max Jan. The network helps show where Max Jan may publish in the future.
Co-authors
The 25 scholars most cited alongside Max Jan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 34 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma Hit paper breakdown → | 2010 | 920 |
| 2 | Clonal Evolution of Preleukemic Hematopoietic Stem Cells Precedes Human Acute Myeloid Leukemia Hit paper breakdown → | 2012 | 620 |
| 3 | The CDK inhibitor CR8 acts as a molecular glue degrader that depletes cyclin K Hit paper breakdown → | 2020 | 347 |
| 4 | 2010 | 323 | |
| 5 | 2015 | 292 | |
| 6 | CAR T cell killing requires the IFNγR pathway in solid but not liquid tumours Hit paper breakdown → | 2022 | 280 |
| 7 | 2011 | 270 | |
| 8 | 2021 | 220 | |
| 9 | Distinct cellular dynamics associated with response to CAR-T therapy for refractory B cell lymphoma Hit paper breakdown → | 2022 | 207 |
| 10 | 2021 | 112 | |
| 11 | 2022 | 112 | |
| 12 | 2023 | 98 | |
| 13 | 2023 | 97 | |
| 14 | 2011 | 97 | |
| 15 | 2021 | 93 | |
| 16 | 2016 | 90 | |
| 17 | Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma Hit paper breakdown → | 2024 | 85 |
| 18 | 2019 | 58 | |
| 19 | 2019 | 53 | |
| 20 | 2024 | 26 |
About Max Jan
Max Jan is a scholar working on Hematology, Oncology, Immunology, Molecular Biology and Cancer Research, having authored 34 papers that have together received 4.5k indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Protein Degradation and Inhibitors (8 papers), Acute Myeloid Leukemia Research (8 papers), CRISPR and Genetic Engineering (5 papers), Immune Cell Function and Interaction (4 papers), Multiple Myeloma Research and Treatments (4 papers), Hematopoietic Stem Cell Transplantation (4 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Hematology (999 citations), Immunology (1.7k citations), Oncology (1.7k citations), Aging (65 citations) and Genetics (339 citations). Max Jan has collaborated with scholars based in United States, United Kingdom and Spain. Frequent co-authors include Irving L. Weissman, Ravindra Majeti, Mark Ping Chao, Arash Ash Alizadeh, Benjamin L. Ebert, Stephen R. Quake, Thomas M. Snyder, Paresh Vyas, M. Ryan Corces and Christopher Y. Park. Their work appears in journals such as Blood, Science Translational Medicine, Blood Advances, Nature Medicine and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.